EIA’s research, conducted over the past two years, reveals the continued online availability of at least 88 traditional Chinese medicine (TCM) products stated to contain leopard, pangolin and, in a few cases, tiger and rhino, manufactured by 72 Chinese companies which have been licensed by the National Medical Products Administration of China.
EIA has prepared analysis of the draft revision of China's Wildlife Protection Law, published for public comment in October 2020, along with recommendations for further revisions urgently needed to secure positive changes for threatened wildlife, including tigers, leopards, pangolins, elephants, rhinos and bears.
在本报告里，环境调查署曝光了有迹象在制造并销售含有豹骨成分的药品的24家中医药制造商。
EIA research reveals that at least twenty-four Chinese pharmaceutical companies have been listing leopard bones as an ingredient in their traditional medicines, although there are fewer than 450 wild leopards left in that country.
With the announcement that the Standing Committee of the National People’s Congress will make revisions to China’s Wildlife Protection Law, the country’s primary piece of legislation covering wildlife conservation and trade, EIA has prepared comments and specific recommendations (in English and Chinese) to urge positive changes for wildlife.
Despite the rapid proliferation of organised Vietnamese wildlife trafficking networks driving illegal wildlife trade globally, the response from the Government of Vietnam has been inadequate and disproportionate to the scale of wildlife trafficking implicating Vietnamese criminal groups.